Various medicinal products (№13721034)

19 mar

Number: 13721034

Country: Romania

Source: TED


Link to original

To view links to the source need to register

Publication date


19-03-2019

Description


  1. Section I
    1. Name and addresses
      Institutul Oncologic „Prof. Dr. I. Chiricuță” Cluj-Napoca
      Str. Republicii nr. 34–36
      Cluj-Napoca
      400015
      Romania
      Telephone: +40 264590056
      E-mail: [email protected]
      Fax: +40 264590056
    2. Type of the contracting authority:
      Body governed by public law
    3. Main activity:
      Health
  2. Section II
    1. Scope of the procurement:
      1. Title:

        Furnizare diverse medicamente, antineoplazice

        Reference number: 4547125/2019/21
      2. Main CPV code:
        33690000
      3. Type of contract:
        Supplies
      4. Short description:

        Furnizare diverse medicamente, antineoplazice.

      5. Information about lots:
        This contract is divided into lots: no
      6. Total value of the procurement:
        Value excluding VAT: 2 353 283.80 RON
    2. Description
      1. Title:
      2. Additional CPV code(s):

      3. Place of performance:
        Main site or place of performance:

        Farmacia I.O.C.N.

      4. Description of the procurement:

        Nr. lot. Denumire comuna internationala, U.M., pret estimat fara TVA, cantitate necesara, valoare estimata fara TVA:

        — 1 — Bevacizumabum 4 ml flac. 1 130,89; 180; 203 560,20,

        — 2 — Bevacizumabum 16 ml flac. 4 372,95; 310; 1 355 614,50,

        — 18 — Trastuzumabum sol. inj. flac. 6 421,85; 100; 642 185,00,

        — 19 — Trastuzumabum fl. 7 155; 20; 143 100,00,

        — 20 — Trastuzumabum pulb. flac. 11 423,51; 40; 456 940,40,

        — 21 — Pertuzumabum 11 010,66; 15; 165 159,90.

      5. Award criteria:
      6. Information about options:
        Options: no
      7. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      8. Additional information:
  3. Section IV
    1. Description:
      1. Type of procedure:
      2. Information about a framework agreement or a dynamic purchasing system:
      3. Information about electronic auction:
      4. Information about the Government Procurement Agreement (GPA):
        The procurement is covered by the Government Procurement Agreement: no
    2. Administrative information:
      1. Previous publication concerning this procedure:
      2. Information about termination of dynamic purchasing system:
      3. Information about termination of call for competition in the form of a prior information notice:
  4. Section V
    1. Contract No: 1623/7
      Title:

      Furnizare diverse medicamente, antineoplazice

    2. Award of contract
      1. Date of conclusion of the contract: 2019-02-18
      2. Information about tenders:
        Number of tenders received: 8
        The contract has been awarded to a group of economic operators: no
      3. Name and address of the contractor:
        Pharmafarm S.A.
        RO 200106
        Str. Principală nr. 1B/1
        Corunca
        060044
        Romania
        Telephone: +40 214050320
        E-mail: [email protected]
        Fax: +40 214050318
        The contractor is an SME: no
      4. Information on value of the contract/lot (excluding VAT):
        Initial estimated total value of the contract/lot: 2 966 560.00 RON
        Total value of the contract/lot: 2 353 283.80 RON
      5. Information about subcontracting:

  5. Section VI
    1. Additional information
    2. Procedures for review
      1. Review body
        Consiliul Național de Soluționare a Contestațiilor
        Str. Stavropoleos nr. 6, sector 3
        București
        030084
        Romania
        Telephone: +40 213104641
        E-mail: [email protected]
        Fax: +40 213104642 / +40 218900745
      2. Body responsible for mediation procedures

      3. Service from which information about the review procedure may be obtained

    3. Date of dispatch of this notice
      2019-03-14